Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	28.93	91.35	70.85
Graham Fair Price	-18.47	26.25	32.20
PEG	-44.16	-0.96	1.73
Price/Book	-9.31	-5.11	-4.67
Price/Cash Flow	17.51	126.15	107.36
Prices/Earnings	59.09	31.54	19.82
Price/Sales	37.46	24.79	18.03
Price/FCF	17.51	126.15	107.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.76	0.50	0.48
Operating Margin	5.63	0.32	0.30
ROA	-32.11	0.05	0.07
ROE	-0.06	-0.04	31.29
ROIC	0.19	0.12	-33.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	97.82
Dividends QOQ	< 0.005	0.11	1722.20
EBIT QOQ	0.01	-0.17	1397.19
EPS QOQ	0.11	-0.33	184.92
FCF QOQ	-0.19	-0.08	55.92
Revenue QOQ	0.19	-0.22	12.02
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-2.03	-3.16	-55.41
Days Sales Outstanding (DSO)	32.58	38.64	18.59
Inventory Turnover	-44.29	-28.50	35.65
Debt/Capitalization	3.35	3.26	-2.83
Quick Ratio	1.00	1.15	15.34
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-27.96	-27.50	1.65
Cash	1.91	2.41	26.42
Capex	-0.38	-0.17	53.94
Free Cash Flow	1.22	1.11	-8.51
Revenue	7.25	5.67	-21.79
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.49	18.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.97	19.19	20.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating